Jane Preuss Hasselby

Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)

Inna M. Chen, Julia S. Johansen, Susann Theile et al. · Journal of Clinical Oncology · 2022 · 98 citations · Full text

Mode of Delivery Shapes Gut Colonization Pattern and Modulates Regulatory Immunity in Mice

Camilla Hartmann Friis Hansen, Line S F Andersen, Łukasz Krych et al. · The Journal of Immunology · 2014 · 94 citations

Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers

Dan Calatayud, Christian Dehlendorff, Mogens K. Boisen et al. · Biomarker Research · 2017 · 67 citations · Full text

Clinical impact of endoscopic ultrasound-guided through-the-needle microbiopsy in patients with pancreatic cysts

Bojan Kovacevic, Pia Klausen, Charlotte Vestrup Rift et al. · Endoscopy · 2020 · 58 citations

Urokinase‐type plasminogen activator receptor (uPAR) on tumor‐associated macrophages is a marker of poor prognosis in colorectal cancer

Martin Illemann, Ole Didrik Lærum, Jane Preuss Hasselby et al. · Cancer Medicine · 2014 · 54 citations · Full text

Soluble Upar, Tumoral Pathology, Medicine +11